- Research works
- 81 ▼ 15% vs 2013–17
- Citations
- 2.3k 28.8 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: C4X Discovery (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.6×. Every wedge is a field page.
- Veterinary 6.6×
- Biochemistry, Genetics and Molecular Biology 5.5×
- Pharmacology, Toxicology and Pharmaceutics 5.5×
- Chemistry 3.3×
- Neuroscience 2.0×
- Agricultural and Biological Sciences 1.9×
- Medicine 1.7×
- Earth and Planetary Sciences 1.0×
- Materials Science 1.0×
- Psychology 0.9×
- Immunology and Microbiology 0.7×
- Business, Management and Accounting 0.5×
- Environmental Science 0.4×
- Computer Science 0.3×
- Physics and Astronomy 0.2×
- Engineering 0.2×
Which keywords describe research at C4X Discovery (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Pharmacokinetics, Medicinal Chemistry, Molecular Docking, Oxidative Stress, Drug Target Identification, Virtual Screening, Drug Metabolism and Cytochrome P450.
- Animal Research Reporting
- Therapeutic Antibodies
- Neurodegenerative Diseases
- Keap1-Nrf2-ARE Pathway
- Biopharmaceuticals
- Glycosylation
- Precision Medicine
- Chiral Separation
- Multidrug Resistance
- Mitochondrial Dysfunction
- Nuclear Receptors
- Biomarkers
- Monoclonal Antibodies
- Cancer Therapy
- Genetic Variation
- Drug Metabolism
- Inflammation
- Molecular Docking
- Machine Learning
- Oxidative Stress
- Pharmacokinetics
- Medicinal Chemistry
- Cancer
- Drug Target Identification
- Virtual Screening
- Cytochrome P450
- Pharmacogenetics
- Metabolic Regulation
- Transcriptional Regulation
- Chemoprevention
- Cell Death
- ATP-dependent Transporters
- Publication Bias
- Liquid Chromatography
- Crystal Structure
- Regenerative Medicine
- Immunogenicity
- Molecular Mechanisms
- Nrf2
- ARRIVE Guidelines
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Pharmacokinetics8▲ 38×4 topics
- Oxidative Stress6▲ 3.9×14 topics
- Medicinal Chemistry6▲ 18×6 topics
- Machine Learning5▲ 3.0×6 topics
- Cancer5▲ 4.1×18 topics
- Molecular Docking4▲ 39×2 topics
- Drug Target Identification4▲ 73×1 topic
- Inflammation4▲ 2.2×17 topics
- Virtual Screening4▲ 73×1 topic
- Drug Metabolism4▲ 87×2 topics
- Cytochrome P4504▲ 63×2 topics
- Genetic Variation4▲ 14×1 topic
- Pharmacogenetics4▲ 111×1 topic
- Cancer Therapy4▲ 6.7×10 topics
- Metabolic Regulation4▲ 15×3 topics
- Monoclonal Antibodies3▲ 24×3 topics
- Transcriptional Regulation2▲ 12×8 topics
- Biomarkers2▲ 4.7×7 topics
- Chemoprevention2▲ 32×2 topics
- Nuclear Receptors2▲ 15×4 topics
- Cell Death2▲ 12×3 topics
- Mitochondrial Dysfunction2▲ 7.2×5 topics
- ATP-dependent Transporters2▲ 48×1 topic
- Multidrug Resistance2▲ 41×1 topic
- Publication Bias2▲ 41×2 topics
- Chiral Separation2▲ 17×1 topic
- Liquid Chromatography2▲ 14×1 topic
- Precision Medicine2▲ 6.8×3 topics
- Crystal Structure2▲ 7.8×4 topics
- Glycosylation2▲ 8.9×3 topics
- Regenerative Medicine2▲ 8.9×3 topics
- Biopharmaceuticals2▲ 27×2 topics
- Immunogenicity2▲ 36×2 topics
- Keap1-Nrf2-ARE Pathway2▲ 72×1 topic
- Molecular Mechanisms2▲ 10.0×3 topics
- Neurodegenerative Diseases2▲ 8.4×4 topics
- Nrf22▲ 72×1 topic
- Therapeutic Antibodies2▲ 14×2 topics
- ARRIVE Guidelines1▲ 107×1 topic
- Animal Research Reporting1▲ 107×1 topic
Which research topics does C4X Discovery (United Kingdom) publish most on?
By volume in 2022–2025: Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Inflammatory mediators and NSAID effects and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 2 Protein Degradation and Inhibitors Molecular Biology 1 works
- 3 Inflammatory mediators and NSAID effects Pharmacology 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 Peptidase Inhibition and Analysis Oncology 1 works
- 6 PARP inhibition in cancer therapy Oncology 0 works
- 7 DNA Repair Mechanisms Molecular Biology 0 works
- 8 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
- 9 Synthesis and Biological Evaluation Organic Chemistry 0 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has C4X Discovery (United Kingdom)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Manchester
- University of Manchester
- Manchester Metropolitan University
- Manchester Royal Infirmary
- Manchester Academic Health Science Centre
- The Christie Hospital
- Manchester University NHS Foundation Trust
- Cancer Research UK Manchester Institute
- Wythenshawe Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.